Quantum Biopharma (QNTM) Market Capitalization (2019 - 2026)

Quantum Biopharma has disclosed Market Capitalization across 8 years of filings, most recently posting $14.1 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 38.87% year-over-year to $14.1 million; the TTM figure through Jun 2026 stood at $14.1 million (down 38.87% YoY), while the FY2025 annual figure was $28.4 million, up 578.33% from the prior year.
• Market Capitalization came in at $14.1 million for Q2 2026 at Quantum Biopharma, down from $18.8 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $3.9 billion in Q1 2023 to a low of $4.2 million in Q4 2024.
• Average Market Capitalization over 5 years is $1.2 billion, with a median of $854.1 million recorded in 2024.
• Year-over-year, Market Capitalization slumped 99.77% in 2024 and jumped 578.33% in 2025.
• Over 5 years, Market Capitalization stood at $2.0 billion in 2022, then slipped by 9.78% to $1.8 billion in 2023, then tumbled by 99.77% to $4.2 million in 2024, then jumped by 578.33% to $28.4 million in 2025, then sank by 50.41% to $14.1 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $14.1 million in Q2 2026, $18.8 million in Q1 2026, and $28.4 million in Q4 2025.